These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30134598)

  • 21. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options for mucinous ovarian carcinoma.
    Gorringe KL; Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Bowtell DDL; Christie M; Chiew YE; Churchman M; DeFazio A; Fereday S; Gilks CB; Gourley C; Hadley AM; Hendley J; Hunter SM; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Pyman J; Rowley SM; Salazar C; Saunders H; Semple T; Stephens AN; Thio N; Torres MC; Traficante N; Zethoven M; Antill YC; Campbell IG; Scott CL
    Gynecol Oncol; 2020 Mar; 156(3):552-560. PubMed ID: 31902686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis.
    Cheng A; Li M; Kanis MJ; Xu Y; Zhang Q; Cui B; Jiang J; Zhang Y; Yang X; Kong B
    Gynecol Oncol; 2017 Jan; 144(1):215-222. PubMed ID: 27889016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
    Koh I; Hinoi T; Sentani K; Hirata E; Nosaka S; Niitsu H; Miguchi M; Adachi T; Yasui W; Ohdan H; Kudo Y
    Cancer Med; 2016 Jul; 5(7):1546-55. PubMed ID: 27060927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita.
    Tummala H; Walne A; Buccafusca R; Alnajar J; Szabo A; Robinson P; McConkie-Rosell A; Wilson M; Crowley S; Kinsler V; Ewins AM; Madapura PM; Patel M; Pontikos N; Codd V; Vulliamy T; Dokal I
    Am J Hum Genet; 2022 Aug; 109(8):1472-1483. PubMed ID: 35931051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucinous borderline ovarian tumors with BRAF
    Ohnishi K; Nakayama K; Ishikawa M; Ishibashi T; Yamashita H; Nakamura K; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Arch Gynecol Obstet; 2020 Aug; 302(2):487-495. PubMed ID: 32556513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
    Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
    Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthase pharmacogenetics.
    Marsh S
    Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
    Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
    Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA.
    Dolnick BJ
    Nucleic Acids Res; 1993 Apr; 21(8):1747-52. PubMed ID: 8493092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distinct molecular profile associated with mucinous epithelial ovarian cancer.
    Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry JP; Scolyer RA; Smith AN; Bali A; Vanden Bergh P; Baron-Hay S; Scott C; Fink D; Hacker NF; Sutherland RL; O'Brien PM
    Br J Cancer; 2006 Mar; 94(6):904-13. PubMed ID: 16508639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.
    Guan X; Liu H; Ju J; Li Y; Li P; Wang LE; Brewster AM; Buchholz TA; Arun BK; Wei Q; Liu Z
    Mol Carcinog; 2015 Apr; 54(4):281-90. PubMed ID: 24166930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
    Kelemen LE; Bandera EV; Terry KL; Rossing MA; Brinton LA; Doherty JA; Ness RB; Kjaer SK; Chang-Claude J; Köbel M; Lurie G; Thompson PJ; Carney ME; Moysich K; Edwards R; Bunker C; Jensen A; Høgdall E; Cramer DW; Vitonis AF; Olson SH; King M; Chandran U; Lissowska J; Garcia-Closas M; Yang H; Webb PM; Schildkraut JM; Goodman MT; Risch HA; ;
    BMC Cancer; 2013 Jan; 13():28. PubMed ID: 23339562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.
    Lassus H; Laitinen MP; Anttonen M; Heikinheimo M; Aaltonen LA; Ritvos O; Butzow R
    Lab Invest; 2001 Apr; 81(4):517-26. PubMed ID: 11304571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele.
    Gusella M; Bolzonella C; Crepaldi G; Ferrazzi E; Padrini R
    Pharmacogenomics J; 2006; 6(6):421-4. PubMed ID: 16868573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.
    Cho HJ; Park YS; Kang WK; Kim JW; Lee SY
    Ther Drug Monit; 2007 Apr; 29(2):190-6. PubMed ID: 17417073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
    Kotoula V; Krikelis D; Karavasilis V; Koletsa T; Eleftheraki AG; Televantou D; Christodoulou C; Dimoudis S; Korantzis I; Pectasides D; Syrigos KN; Kosmidis PA; Fountzilas G
    BMC Cancer; 2012 Aug; 12():342. PubMed ID: 22866924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
    Nakamura K; Reid BM; Chen A; Chen Z; Goode EL; Permuth JB; Teer JK; Tyrer J; Yu X; Kanetsky PA; Pharoah PD; Gayther SA; Sellers TA; Lawrenson K; Karreth FA
    Am J Hum Genet; 2022 Jan; 109(1):116-135. PubMed ID: 34965383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.